Form 4 for INO INOVIO PHARMACEUTICALS, INC.
Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-09 · accession 0001055726-21-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-11 | 2021-08-09 | INO | Humeau Laurent | CSO | S - Sale | $9.15 | -10.3K | 68.6K | -13% | -$94.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-09 | S | D | 10,317 | $9.15 | 68,587 | D | — | — | (F2) These transactions were executed in multiple trades at prices ranging from $9.08 to $9.22, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. |